Natera shared on X:
“Four of our abstracts were selected for oral presentations at the American Society for Radiation Oncology (ASTRO) 2026 Annual Meeting, showcasing the expanding clinical utility of Signatera across tumor types and treatment settings.
Learn more about our latest data:”
Other articles about Radiation Oncology on OncoDaily.
